Search

everythinglearnresearchcommunity

for

Search:↓

Male pattern baldness may indicate arterial stiffness in transgender men on long-term testosterone therapy.

Platelet-rich plasma therapy can reduce hair loss and enhance hair growth in androgenetic alopecia patients, with no side effects observed.

Obese and non-obese women with PCOS have higher heart risk markers, especially if they are obese.

Korean Red Ginseng may improve skin condition and reduce allergy markers in atopic dermatitis patients.

Certain ESR1 gene variations may affect hormone levels and fat distribution in women with high male hormone levels.

The research found different metabolism changes in PCOS patients and suggested new potential markers for diagnosing PCOS with or without insulin resistance.

The study concluded that both anti-Mullerian hormone and LH/FSH ratio are higher in women with PCOS and combining these markers with BMI could improve diagnosis accuracy.

Ayurvedic Panchakarma therapy, Virechan, can effectively manage PCOS symptoms and improve health markers.

Finasteride treatment lowers urine androgen and prostaglandin levels, making them potential markers for effectiveness.

The document suggests that clinical trials for PCOS should focus on meaningful primary outcomes like live birth rates, rather than less reliable surrogate markers.

Scalp cooling to prevent hair loss from chemotherapy works for some but not all, and studying hair damage markers could improve prevention and treatment.

Men using steroids or finasteride to look more attractive may harm their fertility and sexual function, creating a paradox where they seem fit but may be less able to reproduce.

Finasteride lowers PSA levels in men, certain factors increase testicular cancer risk, and current guidelines for penile cancer may lead to unnecessary surgeries.

Some skin conditions may indicate metabolic syndrome, which could help with early detection and management of related health issues.

The research concluded that selection significantly shaped the genetic variation of the X chromosome, with certain regions affected by past selective events.

Caucasian and Asian women with PCOS generally show similar symptoms, except Asian women have less chest hair.

Women with PCOS in North China often have hirsutism and acne, with hirsutism linked to metabolic issues.

Synthetic cannabinoid addiction can cause skin problems like acne and hair loss.

PSA levels could help detect illegal steroid use in female athletes but face challenges like cost and PCOS prevalence.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Clinical signs of excess male hormones and actual hormone levels in the blood do not always match in women with polycystic ovary syndrome.

Isoflavone may help manage PCOS symptoms, but its effectiveness is uncertain.

PSA might help diagnose PCOS and related skin issues, but more research is needed.

Dermal Papilla Cells grown in 3D and with stem cells better mimic natural hair growth conditions than cells grown in 2D.

Lichen planus may be associated with a higher risk of metabolic syndrome.

Excessive hair growth in women can be treated with medications like spironolactone and finasteride, and male-pattern baldness in women can be improved with similar treatments.

Female hair loss can be diagnosed using specific trichoscopy criteria.

Polycystic Ovary Syndrome (PCOS) is a common condition in women that can cause metabolic, reproductive, and psychological issues, and requires lifestyle changes and medication for management.

Antiandrogens like flutamide are effective in treating conditions like prostate cancer and hair loss, but there's a need for more potent versions. Understanding their structure can help develop better treatments.

Ruxolitinib effectively regrows hair in most patients with severe hair loss.